Study of head and neck cancer treatment by administration of autologous cytotoxic lymphocyte induced by stimulation with tumor cell. Effect of adoptive immunotherapy by intra-arterial infusion of killer cells stimulated by autologous tumor in patients with maxillary carcinoma.
1) Grimm EA, Mazumder A, Zhang HZ et al: Lymphokine-activated killer phenomenon. J Exp Med 155: 1823-1841, 1982.
2) Rosenberg SA, Lotze MT, Muul LM et al: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-iose interleukin-2 alone. N Eng J Med 316: 889-897, 1987.
4) Vose BM, Bonnard GD: Specific cytotoxicity against autologous tumor and proliferative responses of human lymphocytes grown in interleukin-2. Int J Cancer 29: 33-39, 1982.